Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of our study is to investigate CSF and blood biomarkers among the subjects with mild cognitive impairment (MCI) and Alzheimer's disease (AD) as well as normal controls.
Alzheimer's disease is the most prevalent cause of dementia. A biomarker is a variable that are measured in vivo and indicate specific features of disease related molecular mechanisms and pathologic changes, including amyloid processing and aggregation, tau hyperphosphorylation, accumulation of neurofibrillary tangles, synaptic dysfunction, neurodegeneration, and loss of brain tissue.
We examine serum oligomeric beta-amyloid 42 and CSF monomeric beta-amyloid 42, total tau and phosphorylated tau, as well as PiB-PET, FDG-PET and brain MRI in 90 participants (30 normal controls, 30 patients with mild cognitive impairment, 30 patients with Alzheimer's disease).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Biomarker study | Other | Oligomeric beta-amyloid 42 in serum, as well as, monomeric beta-amyloid 42, total tau and phosphorylated tau in CSF |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Biomarker | Other | Oligomeric beta-amyloid 42 in serum, as well as, monomeric beta-amyloid 42, total tau and phosphorylated tau in CSF |
|
| Measure | Description | Time Frame |
|---|---|---|
| Oligomeric beta-amyloid 42 in serum | To compare oligomeric beta-amyloid 42 in serum among normal controls, MCI and AD | baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Total tau concentration in CSF | To compare total tau concentration in CSF among normal controls, MCI and AD | baseline |
| Phosphorylated tau concentration in CSF | To compare phosphorylated tau concentration in CSF among normal controls, MCI and AD |
| Measure | Description | Time Frame |
|---|---|---|
| PiB PET | To compare the uptake of PiB PET among normal controls, MCI and AD | baseline |
| FDG-PET | To compare the pattern of hypometabolism with FDG-PET among normal controls, MCI and AD |
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Young Ho Park, MD | Contact | 82-10-6287-8084 | kumimesy@gmail.com | |
| SangYun Kim, MD, PhD | Contact | 82-31-787-7462 | neuroksy@snu.ac.kr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul National University College of Medicine, Seoul National University Bundang Hospital | Recruiting | Seongnam-si | Gyeonggi-do | 463-707 | South Korea |
| Type | Date | Date Unknown |
|---|---|---|
| Release | Apr 20, 2016 | |
| Reset | May 26, 2016 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Apr 20, 2016 | May 26, 2016 |
| ID | Term |
|---|---|
| D000544 | Alzheimer Disease |
| D060825 | Cognitive Dysfunction |
| ID | Term |
|---|---|
| D003704 | Dementia |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D015415 | Biomarkers |
| ID | Term |
|---|---|
| D001685 | Biological Factors |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| baseline |
| Monomeric beta-amyloid 42 in CSF | To compare monomeric beta-amyloid 42 in CSF among normal controls, MCI and AD | baseline |
| baseline |
| Brain MRI | To compare the volumetry and surface morphometry of brain T1-weighted MRI among normal controls, MCI and AD | baseline |
| D024801 |
| Tauopathies |
| D019636 | Neurodegenerative Diseases |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D003072 | Cognition Disorders |